Vivani Medical Statistics
Total Valuation
Vivani Medical has a market cap or net worth of $69.62 million. The enterprise value is $66.40 million.
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024, before market open.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Vivani Medical has 55.26 million shares outstanding. The number of shares has increased by 15.66% in one year.
| Shares Outstanding | 55.26M |
| Shares Change (YoY) | +15.66% |
| Shares Change (QoQ) | +5.40% |
| Owned by Insiders (%) | 34.23% |
| Owned by Institutions (%) | 12.28% |
| Float | 30.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.99 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.55, with a Debt / Equity ratio of 0.84.
| Current Ratio | 4.55 |
| Quick Ratio | 4.31 |
| Debt / Equity | 0.84 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -86.10% and return on invested capital (ROIC) is -32.48%.
| Return on Equity (ROE) | -86.10% |
| Return on Assets (ROA) | -29.29% |
| Return on Capital (ROIC) | -32.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$550,068 |
| Employee Count | 44 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.76% in the last 52 weeks. The beta is 3.51, so Vivani Medical's price volatility has been higher than the market average.
| Beta (5Y) | 3.51 |
| 52-Week Price Change | +17.76% |
| 50-Day Moving Average | 1.23 |
| 200-Day Moving Average | 1.47 |
| Relative Strength Index (RSI) | 52.11 |
| Average Volume (20 Days) | 53,772 |
Short Selling Information
The latest short interest is 858,500, so 1.55% of the outstanding shares have been sold short.
| Short Interest | 858,500 |
| Short Previous Month | 900,415 |
| Short % of Shares Out | 1.55% |
| Short % of Float | 2.85% |
| Short Ratio (days to cover) | 12.62 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -25.27M |
| Pretax Income | -25.37M |
| Net Income | -24.20M |
| EBITDA | -24.90M |
| EBIT | -25.27M |
| Earnings Per Share (EPS) | -$0.46 |
Full Income StatementBalance Sheet
The company has $24.92 million in cash and $20.04 million in debt, giving a net cash position of $4.88 million or $0.09 per share.
| Cash & Cash Equivalents | 24.92M |
| Total Debt | 20.04M |
| Net Cash | 4.88M |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | 23.82M |
| Book Value Per Share | 0.43 |
| Working Capital | 20.55M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$20.50 million and capital expenditures -$1.03 million, giving a free cash flow of -$21.52 million.
| Operating Cash Flow | -20.50M |
| Capital Expenditures | -1.03M |
| Free Cash Flow | -21.52M |
| FCF Per Share | -$0.39 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |